- Deep quantitative image analysis toolkit
- Stays focused on real pathology buyer problems
- Scales to organization-wide healthcare rollouts
Visiopharm
Quantitative digital pathology image analysis
SF7.5
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Enable telepathology consult workflowsPathology research and clinical labs
Enable telepathology consult workflowsPathology research and clinical labs
Best for
Pathology research and clinical labs
Pricing
Custom
SoftFinders Score
7.5 / 10
Overview
What is Visiopharm?
Visiopharm is a digital pathology image analysis company serving pathology research and clinical labs with quantitative tissue analysis tools.
- Clinical role: It supports digital slide workflows, image analysis, and case prioritization rather than autonomous diagnosis, with pathologist review remaining essential before clinical sign-off.
- Best-fit environment: Research and clinical pathology labs gain most value when advanced quantitative analysis is central to their digital pathology work.
- Implementation checks: Buyers should assess lab information system integration depth, slide scanner compatibility, and validation evidence for the specific tissue types under review.
- Commercial model: Pricing is sales-led and scoped per buyer rather than posted publicly, while advanced analysis can involve a steeper learning curve.
A focused pilot around one defined workflow is a practical way to assess Visiopharm before adoption.
KEY FEATURES
What you get out of the box
Research Modules
Modules for translational research workflows
Case Sharing
Shares cases across teams for second review
Slide Management
Manages and routes digitized pathology slides
Image Analysis
AI-assisted analysis of tissue images
Biomarker Tools
Tools to explore quantitative biomarkers
Workflow Routing
Routes cases through pathology lab steps
USE CASES
Where teams put it to work
Enable telepathology consult workflows
Manage digital pathology slides centrally
Support biomarker workflows for research
Route cases for specialty review
Prioritize complex pathology cases
Bridge pathology labs and biopharma
Editorial Take
What we like, and what to verify
- Steeper learning curve for advanced analysis
- Pathologist sign-off required on every case
- Pricing is sales-led and needs scoping upfront
Screenshots
A look inside
Alternatives
Tools to consider next
Ibex Medical Analytics SF 7.8
Why consider it
AI cancer detection for biopsy slides
Indica Labs SF 7.6
Why consider it
HALO digital pathology image analysis platform
OptraHEALTH SF 6.8
Why consider it
AI for pathology and genomics knowledge
Aiforia SF 7.4
Why consider it
Cloud deep learning for tissue analysis
Mindpeak SF 7.2
Why consider it
Consistency-focused AI tumor analysis tools
PreciseDx SF 7
Why consider it
Quantitative AI cancer grading and risk
FAQ